The NIH and NCI SBIR Development Center will host a pre-proposal public meeting and webinar for the following three Technology Transfer Contract Topics:
310 Simplified Tissue Microarray Instrument For Clinical and Research Settings
311 High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
075 A Low Molecular Weight Thyroid-Stimulating Hormone Receptor Agonist for Thyroid Cancer *Note: This cancer-related topic is issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funding will be provided by NIDDK while the receipt, review, and contracting will be handled by NCI.
Date: October 7, 2011
Time: 10:00 a.m. – 1:00 p.m.
Location: William H. Natcher Building, Room A, Bethesda, MD
Meeting participants will learn the technical background for these topics and the processes for licensing these technologies from NIH. The brief presentations will be followed by interactive questions and answers with the in-person and webinar audience. Interested applicants can participate in-person or via a live webinar.
For details on how to participate and to register, please click here.
To view the Technology Transfer Topics 310, 311, and 075, as well as the other contract funding opportunities available from the NCI, visit: http://sbir.cancer.gov/funding/contracts/.
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.